MEDIFAST INC (MED)

US58470H1014 - Common Stock

33.71  +0.21 (+0.63%)

After market: 33.71 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025
Revenue
YoY % growth
1.526B
63.25%		1.599B
4.75%		1.072B
-32.94%		701.29M
-34.58%
EBITDA
YoY % growth
223M
50.17%		195.8M
-12.20%		139.509M
-28.75%		44.491M
-68.11%
EBIT
YoY % growth
216.2M
53.12%		184.8M
-14.52%		126.402M
-31.60%		23.281M
-81.58%
Operating Margin
14.17%11.56%11.79%3.32%
EPS
YoY % growth
13.89
51.64%		13.55
-2.45%		9.11
-32.77%		1.92
-78.89%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		0.79
-78.53%
Revenue
Q2Q % growth		170.59M
-51.12%
EBITDA
Q2Q % growth		13.938M
EBIT
Q2Q % growth		10.353M
-80.65%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 0.55
-83.18%		0.97-0.42-43.28%
Q3 2023
Q2Q % growth		 2.12
-35.17%		1.081.0497.09%
Q2 2023
Q2Q % growth		 2.77
-19.01%		1.451.3290.46%
Q1 2023
Q2Q % growth		 3.67
2.23%		2.421.2551.53%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 191.015M
-43.35%		185.99M5.025M2.70%
Q3 2023
Q2Q % growth		 235.9M
-39.57%		234.42M1.48M0.63%
Q2 2023
Q2Q % growth		 296.2M
-34.66%		272.95M23.25M8.52%
Q1 2023
Q2Q % growth		 349M
-16.43%		322.71M26.29M8.15%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -49.02% 0% -75.19%
Revenue0% -17.92% 0% -22.62%